Literature DB >> 4427232

Aromatic hydroxylation and alkyl oxidation in metabolism of mitotane (o,p'-DDD) in humans.

V D Reif, J E Sinsheimer, J C Ward, D E Schteingart.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4427232     DOI： 10.1002/jps.2600631113

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN： 0022-3549            Impact factor:   3.534


× No keyword cloud information.
  4 in total

Review 1.  Current and emerging therapies for advanced adrenocortical carcinoma.

Authors:  Lyndal J Tacon; Ruth S Prichard; Patsy S H Soon; Bruce G Robinson; Roderick J Clifton-Bligh; Stan B Sidhu
Journal:  Oncologist       Date:  2011-01-06

2.  Comparison of the adrenalytic activity of mitotane and a methylated homolog on normal adrenal cortex and adrenal cortical carcinoma.

Authors:  D E Schteingart; J E Sinsheimer; R E Counsell; G D Abrams; N McClellan; T Djanegara; J Hines; N Ruangwises; R Benitez; L L Wotring
Journal:  Cancer Chemother Pharmacol       Date:  1993       Impact factor: 3.333

3.  Blood levels of o,p'-DDD following administration in various vehicles after a single dose and during long-term treatment.

Authors:  A J Moolenaar; H van Slooten; A P van Seters; D Smeenk
Journal:  Cancer Chemother Pharmacol       Date:  1981       Impact factor: 3.333

4.  Population Pharmacokinetics Modelling and Simulation of Mitotane in Patients with Adrenocortical Carcinoma: An Individualized Dose Regimen to Target All Patients at Three Months?

Authors:  Yoann Cazaubon; Yohann Talineau; Catherine Feliu; Céline Konecki; Jennifer Russello; Olivier Mathieu; Zoubir Djerada
Journal:  Pharmaceutics       Date:  2019-10-31       Impact factor: 6.321
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.